Sitagil 50mg Tablet

What is Sitagil?

Sitagil is a brand of Sitagliptin manufactured by Incepta Pharmaceuticals Ltd. It belongs to the DPP-4 inhibitor class, used to improve blood glucose control in adults with type 2 diabetes mellitus, generally well tolerated with a low risk of hypoglycemia and weight gain.

Generic Name and Composition

Each tablet contains 50 mg of Sitagliptin (as phosphate monohydrate).

Indications

• Type 2 diabetes mellitus, as monotherapy or in combination with metformin, sulfonylureas, thiazolidinediones, or insulin
• Used as an adjunct to diet and exercise to improve glycemic control

How It Works — Mechanism of Action

Sitagliptin inhibits the DPP-4 enzyme, slowing the breakdown of incretin hormones (GLP-1 and GIP). This increases insulin release and decreases glucagon secretion in a glucose-dependent manner, helping lower blood glucose levels without a high risk of hypoglycemia when used alone.

Dosage and Administration

• Dosage is individualized by a physician; typically once daily, with or without food.
• Swallow the tablet whole with water.
• Take at the same time each day for consistent results.
• Do not change the dose without consulting your physician.

Side Effects

Common: Headache, upper respiratory tract infection, nasopharyngitis.

Uncommon: Nausea, diarrhea, abdominal pain, hypoglycemia (especially when combined with sulfonylureas or insulin).

Rare: Pancreatitis, severe joint pain, hypersensitivity reactions, bullous pemphigoid (skin blistering).

Drug Interactions

May enhance hypoglycemia: Insulin, sulfonylureas — dose adjustment of these agents may be needed when combined with sitagliptin.

Other considerations: Inform your doctor of all medicines you are taking, including over-the-counter drugs and supplements.

Contraindications

• Known hypersensitivity to sitagliptin or any excipient
• History of serious hypersensitivity reaction to a DPP-4 inhibitor, including anaphylaxis or angioedema
• Type 1 diabetes mellitus or diabetic ketoacidosis

Pregnancy and Lactation

Sitagliptin is generally not recommended during pregnancy or breastfeeding due to limited safety data. Insulin is typically preferred for glycemic control in these situations. Consult your physician for an appropriate alternative if pregnant or breastfeeding.

Precautions and Warnings

• Seek medical attention immediately for symptoms of pancreatitis (persistent severe abdominal pain, possibly radiating to the back, with or without vomiting).
• Discontinue and seek medical care if signs of severe skin blistering or hypersensitivity reaction occur.
• Use with caution in patients with renal impairment — dose adjustment may be required.
• Monitor blood glucose regularly, especially when combined with insulin or sulfonylureas.

Overdose

Limited data exists on sitagliptin overdose. Management is supportive, focusing on monitoring vital signs and blood glucose, with appropriate clinical intervention as needed. Seek immediate medical attention in case of suspected overdose.

Storage Instructions

• Store below 30°C in a dry place, protected from light.
• Keep out of reach of children.
• Do not use after the expiry date printed on the pack.

Frequently Asked Questions

Q1: When should I take Sitagil 50mg?
It is usually taken once daily, with or without food, at the same time each day for best results.

Q2: Can Sitagil cause low blood sugar on its own?
Used alone, the risk of hypoglycemia is low. Risk increases when combined with insulin or sulfonylureas.

Q3: Does Sitagil cause weight gain?
Sitagliptin is generally weight-neutral, unlike some other diabetes medications such as sulfonylureas or insulin.

Q4: How is Sitagil different from Dapaglip?
Sitagil (sitagliptin) is a DPP-4 inhibitor that boosts the body's own incretin hormones, while Dapaglip (dapagliflozin) is an SGLT2 inhibitor that removes excess glucose through urine. Both are oral antidiabetics but work through different mechanisms.

Medical Disclaimer

This product is available by prescription only (Rx). The information provided is for educational purposes and does not replace professional medical advice. Always consult a registered physician before starting, stopping, or changing any diabetes therapy. DiabetesStore.com.bd is a licensed online pharmacy in Bangladesh.